Newsletter No. 3, 2019

Welcome to RLS Global Newsletter

At the beginning of May, RLS participated in the Symposium of Advanced Wound Care (SAWC) which took place in San Antonio, Texas, May 7th-11th. The meeting serves as a forum to connect the entire wound care team; physicians, nurses, physical therapists, researchers, scientists, podiatrists and dietitians. The aim and purpose are to share the latest news within research and development which will improve patient outcomes through education.

Attending meetings such as SAWC is tremendously inspiring, to learn about the future research trends, new product innovations and finally – the great networking opportunity. Below you can read about a few “hot topics” discussed during SAWC.

Trends and Learnings from SAWC

I had the pleasure to attend several of presentations talking about the importance of good debridement to secure efficient wound healing. It is all about how to manage biofilms to stimulate the healing process. Biofilms are the collective name of one or more types of microorganisms that can grow on many different surfaces and cause infection. According to the research, this is one of the most important aspects for an efficient wound care. Biofilms can have a significant negative impact on wound healing by contributing to bacterial infection and inflammation and hence cause a delay of the wound healing process. And managing biofilms is exactly what ChloraSolv is all about!

ChloraSolv is a unique gentle method for easy wound debridement. It facilitates gentle removal of devitalized/necrotic tissue which can include biofilm. It is very encouraging to listen to the researchers and review the latest data that really supports ChloraSolv’s mode of action.

Another hot topic during the meeting was the future development of Biomarkers within the diagnosis and personalized treatment of chronic wounds. The science is moving rapidly, and in the future, biomarkers can be used to optimize treatment of chronic wounds. Biomarkers play a vital role in the development of new inventive therapies. The more understanding and information the clinicians can get about the wound and its conditions, the better treatment can be offered. This will drive the awareness of the importance of efficient debridement to optimize the wound healing.

Attending SAWC is also an excellent opportunity to further build a clinical- and business network relevant for RLS Global. The interest for RLS and our debridement product is definitely much stronger now when ChloraSolv is CE approved. A lot of interesting discussions took place in regards of our journey going forward. As we know, several of the global players have a gap in the portfolio when it comes to efficient debridement products.

The European Wound Management Association (EWMA) annual conference takes place in Gothenburg in about three weeks’ time. The conference will bring 2500 delegates. The objectives of EWMA is to support implementation of interdisciplinary and cost-effective wound care of high quality. On top of that, this year RLS Global will officially launch ChloraSolv during the conference!

Attending meetings such as SAWC and EWMA are tremendously inspiring, to learn about the future research trends, new product innovations and of course the great networking.

Last but not least – Dental 24 accepted a debate article written by RLS last week. It is about the importance to learn and implement the philosophy about Minimal Invasive Treatment. You can reach the article via the link below:

I want to take the opportunity to welcome our shareholders to the annual meeting taking place the 29th of May. You will find the invite via the link below:

Karin Fischer, CEO
RLS Global AB